hTERT/survivin mRNA-loaded dendritic cell vaccination combined with ex-vivo expanded T cell transfer in stage IV melanoma patients show a longer overall survival in patients with sustained immune responses against hTERT
Bigalke, I., Torhaug, S.B., Lundby, M., Mollatt, C., Inderberg-Suso, E., Kolstad, A., Gaudernack, G., Rasmussen, A., Aamdal, S., Kvalheim, G.Volume:
16
Language:
english
Journal:
Cytotherapy
DOI:
10.1016/j.jcyt.2014.01.066
Date:
April, 2014
File:
PDF, 48 KB
english, 2014